SC 13G

SCHEDULE 13G

Company: Regencell Bioscience Holdings Ltd
Filed: December 15, 2021
Accession Number: 0001213900-21-065364

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →

View Document ↗ View on SEC.gov ↗